FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiltrud Brauch

Research Profile

Disorders

Physiology

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Justo Lorenzo Bermejo; Hiltrud Brauch; Thomas Brüning; Thomas Dünnebier; Hans-Peter Fischer; Christian Baisch; Volker Harth; Christina Justenhoven; Maria Kabisch; Yon-Dschun Ko; Frauke Melchior; Beate Pesch; Sylvia Rabstein; Sven Schnaidt; Ute Hamann
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.
Pilar H Saladores; Werner Schroth; Hiltrud Brauch; Jana C Precht; Matthias Schwab
Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer.
Ofure Obazee; Beate Pesch; Sylvia Rabstein; Anja Rudolph; Petra Seibold; Gianluca Severi; Melissa Southey; Stefan Winter; Thomas Brüning; Jenny Chang-Claude; Dieter Flesch-Janys; Graham Giles; Per Hall; Ute Hamann; Ulf Hannelius; Volker Harth; Keith Humphreys; Christina Justenhoven; Yon-Dschun Ko; Jingmei Li; Anne Lotz; Laura Baglietto; Christian Baisch; Hiltrud Brauch
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiltrud Brauch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Justo Lorenzo Bermejo; Hiltrud Brauch; Thomas Brüning; Thomas Dünnebier; Hans-Peter Fischer; Christian Baisch; Volker Harth; Christina Justenhoven; Maria Kabisch; Yon-Dschun Ko; Frauke Melchior; Beate Pesch; Sylvia Rabstein; Sven Schnaidt; Ute Hamann
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.
International journal of cancer. Journal international du cancer 2013;133(2):362-72.
2013: Pilar H Saladores; Werner Schroth; Hiltrud Brauch; Jana C Precht; Matthias Schwab
Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer.
Expert review of molecular diagnostics 2013;13(4):349-65.
2013: Ofure Obazee; Beate Pesch; Sylvia Rabstein; Anja Rudolph; Petra Seibold; Gianluca Severi; Melissa Southey; Stefan Winter; Thomas Brüning; Jenny Chang-Claude; Dieter Flesch-Janys; Graham Giles; Per Hall; Ute Hamann; Ulf Hannelius; Volker Harth; Keith Humphreys; Christina Justenhoven; Yon-Dschun Ko; Jingmei Li; Anne Lotz; Laura Baglietto; Christian Baisch; Hiltrud Brauch
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
Breast cancer research and treatment 2013;138(2):543-8.
2013: Hiltrud Brauch; Matthew P Goetz; James N Ingle; Thomas E Mürdter; Werner Schroth; Matthias Schwab; Stefan Winter; Michel Eichelbaum
Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):176-80.
2012: Christina Justenhoven; Ofure Obazee; Hiltrud Brauch
The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.
Pharmacogenomics 2012;13(6):659-75.
2012: Jana C Precht; Matthias Schwab; Hiltrud Brauch; Boian Ganchev; Georg Heinkele; Thomas E Mürdter
Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS.
Analytical and bioanalytical chemistry 2012;403(1):301-8.
2012: Thomas E Mürdter; Elke Schaeffeler; Werner Schroth; Gabriele M Böhmer; Hiltrud Brauch; Boian Ganchev; Svitlana Igel; Reinhold Kerb; Miia Turpeinen; Ulrich Zanger; Matthias Schwab
Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites.
Human molecular genetics 2012;21(5):1145-54.
2011: Hiltrud Brauch; James N Ingle; Werner Schroth; Matthew P Goetz
CYP2D6 and tamoxifen: awaiting the denouement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4589-90; author reply 4590-1.
2011: V Craig Jordan; Helen R Kim; Ifeyinwa Obiorah; Eric A Ariazi; Heather Cunliffe; Ping Fan; Hiltrud Brauch
The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.
Breast (Edinburgh, Scotland) 2011;20 Suppl 3():S1-11.
2011: Thomas Lang; Beate Pesch; Sylvia Rabstein; Matthias Schwab; Anne Spickenheuer; Stefan Winter; Thomas Brüning; Ute Hamann; Volker Harth; Christina Justenhoven; Yon-Dschun Ko; Christian Baisch; Hiltrud Brauch
The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans.
Breast cancer research and treatment 2011;129(3):993-9.
2011: Martin Filipits; Florian Fitzal; Christa Freibauer; Peter Fritz; Mathias Gehrmann; Michael Gnant; Richard Greil; Guido Hennig; Raimund Jakesz; Fritz Jänicke; Andrea Jelen; Manfred Kaufmann; Heinz Kölbl; Ralf Kronenwett; Volkmar Müller; Achim Rody; Margaretha Rudas; Marcus Schmidt; Werner Schroth; Matthias Schwab; Paul Sevelda; Christian F Singer; Karsten E Weber; Hiltrud Brauch; Otto Dietze; Peter Dubsky; Inke S Feder
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(18):6012-20.
2011: Philip S Crooke; Sheila Dawling; William D Dupont; Kathryn S P Higginbotham; Christina Justenhoven; David L Page; W Dale Plummer; Nady Roodi; Melinda E Sanders; Peggy A Schuyler; Jeffrey R Smith; Hiltrud Brauch; Fritz F Parl
Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(7):1502-15.
2011: Thomas E Mürdter; Werner Schroth; Matthias Schwab; W Simon; S Winter; Michel Eichelbaum; P A Fasching; T Fehm; Georg Heinkele; L Bacchus-Gerybadze; Hiltrud Brauch
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.
Clinical pharmacology and therapeutics 2011;89(5):708-17.
2011: Thomas Dünnebier; Klaus Schlaefer; Michael Gilbert; Christian Baisch; Christina Justenhoven; Hiltrud Brauch; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Ute Hamann
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.
Breast cancer research and treatment 2011;127(1):259-64.
2011: Matthias Schwab; E Schaeffeler; U M Zanger; Hiltrud Brauch; Heyo K Kroemer
[Pharmacogenomics: hype or hope?].
Deutsche medizinische Wochenschrift (1946) 2011;136(10):461-7.
2011: Reiner Hoppe; Deanna L Kroetz; Hiltrud Brauch; Manel Esteller
Exploiting the complexity of the genome and transcriptome using pharmacogenomics towards personalized medicine.
Genome biology 2011;12(1):301.
2011: Laurent Becquemont; Ana Alfirevic; Ursula Amstutz; Hiltrud Brauch; Evelyne Jacqz-Aigrain; Pierre Laurent-Puig; Miguel A Molina; Mikko Niemi; Matthias Schwab; Andrew A Somogyi; Eric Thervet; Anke Hilse Maitland-van der Zee; André Bp van Kuilenburg; Ron Hn van Schaik; Céline Verstuyft; Mia Wadelius; Ann K Daly
Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.
Pharmacogenomics 2011;12(1):113-24.
2011: Christina Justenhoven; Elke Schaeffeler; Stefan Winter; Christian Baisch; Ute Hamann; Volker Harth; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Matthias Schwab; Hiltrud Brauch
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
Breast cancer research and treatment 2011;125(2):563-9.
2010: Guido Hennig; Mathias Gehrmann; Udo Stropp; Hiltrud Brauch; Peter Fritz; Michel Eichelbaum; Matthias Schwab; Werner Schroth
Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression.
Clinical chemistry 2010;56(12):1845-53.
2010: Christina Justenhoven; Stefan Winter; Ute Hamann; Susanne Haas; Hans-Peter Fischer; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Hiltrud Brauch
The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.
Cancer 2010;116(23):5358-64.
2010: Christina Justenhoven; Stefan Winter; Thomas Dünnebier; Ute Hamann; Christian Baisch; Sylvia Rabstein; Anne Spickenheuer; Volker Harth; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Hiltrud Brauch
Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk.
Breast cancer research and treatment 2010;124(1):289-92.
2010: Thomas Lang; Werner Schroth; Hiltrud Brauch; Matthias Schwab
ABCC2 and clinical outcome of tamoxifen therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):e448; author reply e449.
2010: Werner Schroth; Ute Hamann; Peter A Fasching; Silke Dauser; Stefan Winter; Michel Eichelbaum; Matthias Schwab; Hiltrud Brauch
CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4468-77.
2010: Santhi D Konduri; Rajesh Medisetty; Wensheng Liu; Benny Abraham Kaipparettu; Pratima Srivastava; Hiltrud Brauch; Peter Fritz; Wendy M Swetzig; Amanda E Gardner; Sohaib A Khan; Gokul M Das
Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(34):15081-6.
2010: Irena Andonova; Christina Justenhoven; Stefan Winter; Ute Hamann; Christian Baisch; Sylvia Rabstein; Anne Spickenheuer; Volker Harth; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Varban Ganev; Hiltrud Brauch
No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk.
Breast cancer research and treatment 2010;121(2):497-502.
2010: Thomas Dünnebier; Justo Lorenzo Bermejo; Susanne Haas; Hans-Peter Fischer; Christiane Pierl; Christina Justenhoven; Hiltrud Brauch; Christian Baisch; Michael Gilbert; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Ute Hamann
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
Breast cancer research and treatment 2010;121(1):185-94.
2010: Beate Pesch; Volker Harth; Sylvia Rabstein; Christian Baisch; Markus Schiffermann; Dirk Pallapies; Nadine Bonberg; Evelyn Heinze; Anne Spickenheuer; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon Ko; Kurt Straif; Thomas Brüning
Night work and breast cancer - results from the German GENICA study.
Scandinavian journal of work, environment & health 2010;36(2):134-41.
2010: Sylvia Rabstein; Thomas Brüning; Volker Harth; Hans-Peter Fischer; Susanne Haas; Tobias Weiss; Anne Spickenheuer; Christiane Pierl; Christina Justenhoven; Thomas Illig; Caren Vollmert; Christian Baisch; Yon-Dschun Ko; Ute Hamann; Hiltrud Brauch; Beate Pesch
N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2010;19(2):100-9.
2010: Xianshu Wang; Zachary S Fredericksen; Robert A Vierkant; Matthew L Kosel; V Shane Pankratz; James R Cerhan; Christina Justenhoven; Hiltrud Brauch; Janet E Olson; Fergus J. Couch
Association of genetic variation in mitotic kinases with breast cancer risk.
Breast cancer research and treatment 2010;119(2):453-62.
2009: Jianjun Liu; Taru A Muranen; Heli Nevanlinna; Dianbo Qu; Melissa C Southey; Amanda B Spurdle; Karl von Smitten; Kirsimari Aaltonen; Kristiina Aittomäki; Shakeela Banu; Jonathan Beesley; Carl Blomqvist; Carine Bonnard; Hiltrud Brauch; Xiaoqing Chen; Georgia Chenevix-Trench; Kamila Czene; Kartiki Vasant Desai; Per Hall; Tuomas Heikkinen; John L Hopper; Tasneem Shabbir Kajiji; Yew Kok Lee; Yuqing Li; Edison T Liu
Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development.
The HUGO journal 2009;3(1-4):31-40.
2009: Sandra Amaral; Werner Schroth; Sibylle Kugler; Peter Fritz; Wolfgang Simon; Hiltrud Brauch
The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.
Breast cancer research and treatment 2009;118(2):323-31.
2009: Werner Schroth; Matthew P Goetz; Ute Hamann; Peter A Fasching; Marcus Schmidt; Stefan Winter; Peter Fritz; Wolfgang Simon; Vera J Suman; Matthew M Ames; Stephanie L Safgren; Mary J Kuffel; Hans Ulrich Ulmer; Julia Boländer; Reiner Strick; Matthias W Beckmann; Heinz Koelbl; Richard M Weinshilboum; James N Ingle; Michel Eichelbaum; Matthias Schwab; Hiltrud Brauch
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen.
JAMA : the journal of the American Medical Association 2009;302(13):1429-36.
2009: Hiltrud Brauch; Thomas E Mürdter; Michel Eichelbaum; Matthias Schwab
Pharmacogenomics of tamoxifen therapy.
Clinical chemistry 2009;55(10):1770-82.
2009: Hiltrud Brauch; V Craig Jordan
Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the 'personalised' approach?
European journal of cancer (Oxford, England : 1990) 2009;45(13):2274-83.
2009: Thomas Dünnebier; Justo Lorenzo Bermejo; Susanne Haas; Hans-Peter Fischer; Christiane Pierl; Christina Justenhoven; Hiltrud Brauch; Christian Baisch; Michael Gilbert; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Ute Hamann
Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.
International journal of cancer. Journal international du cancer 2009;125(3):596-602.
2009: Christina Justenhoven; Christiane Pierl; Susanne Haas; Hans-Peter Fischer; Ute Hamann; Christian Baisch; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Caren Vollmert; Thomas Illig; Beate Pesch; Thomas Brüning; Jürgen Dippon; Yon-Dschun Ko; Hiltrud Brauch
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.
International journal of cancer. Journal international du cancer 2009;124(9):2077-81.
2009: Christina Justenhoven; Ute Hamann; Christiane Pierl; Christian Baisch; Volker Harth; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Stefan Winter; Yon-Dschun Ko; Hiltrud Brauch
CYP2C19*17 is associated with decreased breast cancer risk.
Breast cancer research and treatment 2009;115(2):391-6.
2009: Susanne Haas; Heidrun Gevensleben; Sylvia Rabstein; Volker Harth; Beate Pesch; Thomas Brüning; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Christian Baisch; Hans-Peter Fischer; Reinhard Büttner
Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers.
Oncology reports 2009;21(2):299-304.
2009: Susanne Haas; Sabine Merkelbach-Bruse; Christina Justenhoven; Hiltrud Brauch; Hans-Peter Fischer
Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
Pathology, research and practice 2009;205(10):716-25.
2009: Olivia Fletcher; Nichola Johnson; Isabel dos Santos Silva; Outi Kilpivaara; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Marijke Wasielewski; Hanne Meijers-Heijerboer; Annegien Broeks; Marjanka K Schmidt; Laura J Van't Veer; Michael Bremer; Thilo Dörk; Elena V Chekmariova; Anna P Sokolenko; Evgeny N Imyanitov; Ute Hamann; M Rashid; Hiltrud Brauch; Christina Justenhoven; Alan Ashworth; Julian Peto
Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):230-4.
2008: Rokavec Matjaz; Werner Schroth; Sandra M C Amaral; Peter Fritz; Lydia Antoniadou; Damjan Glavac; Wolfgang Simon; Matthias Schwab; Michel Eichelbaum; Hiltrud Brauch
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
Cancer research 2008;68(23):9799-808.
2008: Christina Justenhoven; Christiane Pierl; Susanne Haas; Hans-Peter Fischer; Christian Baisch; Ute Hamann; Volker Harth; Beate Pesch; Thomas Brüning; Caren Vollmert; Thomas Illig; Jürgen Dippon; Yon-Dschun Ko; Hiltrud Brauch
The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
Breast cancer research and treatment 2008;111(1):171-7.
2008: Bernd Frank; Sushila H Rigas; Justo Lorenzo Bermejo; Miriam Wiestler; Kerstin Wagner; Kari Hemminki; Malcolm W Reed; Christian Sutter; Barbara Wappenschmidt; Sabapathy P Balasubramanian; Alfons Meindl; Marion Kiechle; Peter Bugert; Rita K Schmutzler; Claus R Bartram; Christina Justenhoven; Yon-Dschun Ko; Thomas Brüning; Hiltrud Brauch; Ute Hamann; Paul P D Pharoah; Alison M Dunning; Karen A Pooley; Douglas F Easton; Angela Cox; Barbara Burwinkel
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study.
Breast cancer research and treatment 2008;111(1):139-44.
2008: Yuan Ji; Janet Olson; Jianping Zhang; Michelle A T Hildebrandt; Liewei Wang; James N Ingle; Zachary S Fredericksen; Thomas A Sellers; William Miller; J Michael Dixon; Hiltrud Brauch; Michel Eichelbaum; Christina Justenhoven; Ute Hamann; Yon Ko; Thomas Brüning; Jenny Chang-Claude; Shan Wang-Gohrke; Daniel J Schaid; Richard M Weinshilboum
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
Cancer research 2008;68(14):5997-6005.
2008: Benny Abraham Kaipparettu; Simeen Malik; Santhi D Konduri; Wensheng Liu; Rokavec Matjaz; Heiko van der Kuip; Reiner Hoppe; Stephanie Hammerich-Hille; Peter Fritz; Werner Schroth; Ina Abele; Gokul M Das; Steffi Oesterreich; Hiltrud Brauch
Estrogen-mediated downregulation of CD24 in breast cancer cells.
International journal of cancer. Journal international du cancer 2008;123(1):66-72.
2008: Christina Justenhoven; Ute Hamann; Falk Schubert; Marc Zapatka; Christiane Pierl; Sylvia Rabstein; Silvia Selinski; Tina Mueller; Katja Ickstadt; Michael Gilbert; Yon-Dschun Ko; Christian Baisch; Beate Pesch; Volker Harth; Hermann M Bolt; Caren Vollmert; Thomas Illig; Roland Eils; Jürgen Dippon; Hiltrud Brauch
Breast cancer: a candidate gene approach across the estrogen metabolic pathway.
Breast cancer research and treatment 2008;108(1):137-49.
2007: Rokavec Matjaz; Christina Justenhoven; Werner Schroth; Monica Istrate; Susanne Haas; Hans-Peter Fischer; Caren Vollmert; Thomas Illig; Ute Hamann; Yon-Dschun Ko; Damjan Glavac; Hiltrud Brauch
A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7506-14.
2007: Werner Schroth; Lydia Antoniadou; Peter Fritz; Matthias Schwab; Thomas Muerdter; Uli Zanger; Wolfgang Simon; Michel Eichelbaum; Hiltrud Brauch
Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5187-93.
2007: Malgorzata Jaremko; Christina Justenhoven; Werner Schroth; Benny K Abraham; Peter Fritz; Caren Vollmert; Thomas Illig; Wolfgang Simon; Matthias Schwab; Hiltrud Brauch
Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
Pharmacogenetics and genomics 2007;17(7):529-38.
2006: Susanne Haas; Christiane Pierl; Volker Harth; Beate Pesch; Sylvia Rabstein; Thomas Brüning; Yon Ko; Ute Hamann; Christina Justenhoven; Hiltrud Brauch; Hans-Peter Fischer
Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas.
International journal of cancer. Journal international du cancer 2006;119(8):1785-91.
2006: Julia Beisner; Miriam B Buck; Peter Fritz; Jürgen Dippon; Matthias Schwab; Hiltrud Brauch; Gerhard Zugmaier; Klaus Pfizenmaier; Cornelius Knabbe
A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.
Cancer research 2006;66(15):7554-61.
2005: Christina Justenhoven; Ute Hamann; Christiane Pierl; Sylvia Rabstein; Beate Pesch; Volker Harth; Christian Baisch; Caren Vollmert; Thomas Illig; Thomas Brüning; Yon Ko; Hiltrud Brauch
One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):3015-8.
2005: M Rashid; Anna Jakubowska; Christina Justenhoven; Volker Harth; Beate Pesch; Christian Baisch; Christiane Pierl; Thomas Brüning; Yon Ko; Axel Benner; H-Erich Wichmann; Hiltrud Brauch; Ute Hamann
German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(18):2896-903.
2005: Derek John Atkins; Christian Gingert; Christina Justenhoven; Gerd Emil Schmahl; Marcellus Stephanus Bonato; Hiltrud Brauch; Stephan Störkel
Concomitant deregulation of HIF1alpha and cell cycle proteins in VHL-mutated renal cell carcinomas.
Virchows Archiv : an international journal of pathology 2005;447(3):634-42.
2005: Benny K Abraham; Christina Justenhoven; Beate Pesch; Volker Harth; Gregor Weirich; Christian Baisch; Sylvia Rabstein; Yon-Dschun Ko; Thomas Brüning; Hans-Peter Fischer; Susanne Haas; Sandra Brod; Christian Oberkanins; Ute Hamann; Hiltrud Brauch
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1102-7.
2005: Malgorzata Jaremko; Christina Justenhoven; Benny K Abraham; Werner Schroth; Peter Fritz; Sandra Brod; Caren Vollmert; Thomas Illig; Hiltrud Brauch
MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET).
Human mutation 2005;25(3):232-8.
2005: Benny K Abraham; Peter Fritz; Monika McClellan; Petra Hauptvogel; Maria Athelogou; Hiltrud Brauch
Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1154-9.
2005: Beate Pesch; Yon Ko; Hiltrud Brauch; Ute Hamann; Volker Harth; Sylvia Rabstein; Christiane Pierl; Hans-Peter Fischer; Christian Baisch; Christina Justenhoven; Ulrich Ranft; Thomas Brüning
Factors modifying the association between hormone-replacement therapy and breast cancer risk.
European journal of epidemiology 2005;20(8):699-711.
2004: Christina Justenhoven; Ute Hamann; Beate Pesch; Volker Harth; Sylvia Rabstein; Christian Baisch; Caren Vollmert; Thomas Illig; Yon-Dschun Ko; Thomas Brüning; Hiltrud Brauch
ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(12):2059-64.
2004: Hiltrud Brauch; Gregor Weirich; Bettina Klein; Sylvia Rabstein; Hermann M Bolt; Thomas Brüning
VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference?
Toxicology letters 2004;151(1):301-10.
2002: Gregor Weirich; Bettina Klein; Thorsten Wöhl; Dieter Engelhardt; Hiltrud Brauch
VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V.
The Journal of clinical endocrinology and metabolism 2002;87(11):5241-6.
2002: Michael Siegsmund; Ulrich Brinkmann; Elke Scháffeler; Gregor Weirich; Matthias Schwab; Michel Eichelbaum; Peter Fritz; Oliver Burk; Jochen Decker; Peter Alken; Uwe Rothenpieler; Reinhold Kerb; Sven Hoffmeyer; Hiltrud Brauch
Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.
Journal of the American Society of Nephrology : JASN 2002;13(7):1847-54.
2001: B Klein; Gregor Weirich; Hiltrud Brauch
DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.
Human genetics 2001;108(5):376-84.
2000: M Krieg; R Haas; Hiltrud Brauch; Till Acker; Ingo Flamme; Karl H Plate
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Oncogene 2000;19(48):5435-43.
2000: Hiltrud Brauch; Gregor Weirich; Jürgen Brieger; Damjan Glavac; H Rödl; M Eichinger; M Feurer; EJ Weidt; C Puranakanitstha; C Neuhaus; S Pomer; W Brenner; Peter Schirmacher; Stephan Störkel; M Rotter; A Masera; N Gugeler; Hans-Jochen Decker
VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Cancer research 2000;60(7):1942-8.
1999: Hiltrud Brauch; Gregor Weirich; MA Hornauer; Stephan Störkel; Thorsten Wöhl; Thomas Brüning
Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.
Journal of the National Cancer Institute 1999;91(10):854-61.
1999: R F Schwerdtle; C Neuhaus; EJ Weidt; Christoph Huber; W Brenner; Rudolf Hohenfellner; Andreas Winterpacht; B Zabel; Hans-Jochen Decker; Stephan Störkel; Hiltrud Brauch
Retraction.
Cancer research 1999;59(8):2021.
1999: L Schmidt; K Junker; N Nakaigawa; T Kinjerski; Gregor Weirich; M Miller; Irina A Lubensky; H P Neumann; Hiltrud Brauch; J Decker; Cathy D Vocke; James A Brown; R Jenkins; S Richard; U Bergerheim; B Gerrard; M Dean; W Marston Linehan; Berton Zbar
Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Oncogene 1999;18(14):2343-50.
1998: Hartmut P H Neumann; Bernhard U Bender; Dietmar P Berger; Jörg Laubenberger; Wolfgang Schultze-Seemann; Ulrich Wetterauer; F J Ferstl; E W Herbst; Georg Schwarzkopf; Frederik J Hes; Cornelis J M Lips; J M Lamiell; O Masek; Peter Riegler; B Mueller; Damjan Glavac; Hiltrud Brauch
Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.
The Journal of urology 1998;160(4):1248-54.
1997: Gregor Weirich; MA Hornauer; T Brüning; H Höfler; Hiltrud Brauch
Fixed archival tissue. Purify DNA and primers for good PCR yield!
Molecular biotechnology 1997;8(3):299-301.
1997: Hiltrud Brauch; W Hoeppner; H Jähnig; Thorsten Wöhl; D Engelhardt; F Spelsberg; MM Ritter
Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
The Journal of clinical endocrinology and metabolism 1997;82(12):4101-4.
1997: Gregor Weirich; P Schneider; C Fellbaum; Hiltrud Brauch; W Nathrath; M Scholz; HW Präuer; Heinz Höfler
p53 alterations in thymic epithelial tumours.
Virchows Archiv : an international journal of pathology 1997;431(1):17-23.
1997: Ute Hamann; Hiltrud Brauch; A M Garvin; Gunther Bastert; Rodney J Scott
German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Genes, chromosomes & cancer 1997;18(2):126-32.
1997: Thomas Brüning; Gregor Weirich; MA Hornauer; H Höfler; Hiltrud Brauch
Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene.
Archives of toxicology 1997;71(5):332-5.